These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 26547065)

  • 21. Unraveling the epigenetic code of cancer for therapy.
    Smith LT; Otterson GA; Plass C
    Trends Genet; 2007 Sep; 23(9):449-56. PubMed ID: 17681396
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epigenetic perspectives on cancer chemotherapy response.
    Liu MZ; McLeod HL; He FZ; Chen XP; Zhou HH; Shu Y; Zhang W
    Pharmacogenomics; 2014 Apr; 15(5):699-715. PubMed ID: 24798726
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting histone methyltransferases and demethylases in clinical trials for cancer therapy.
    Morera L; Lübbert M; Jung M
    Clin Epigenetics; 2016; 8():57. PubMed ID: 27222667
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Naturally occurring small molecule compounds that target histone deacetylases and their potential applications in cancer therapy.
    Maemoto Y; Shimizu Y; Katoh R; Ito A
    J Antibiot (Tokyo); 2021 Oct; 74(10):667-676. PubMed ID: 34426659
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plant phytochemicals as epigenetic modulators: role in cancer chemoprevention.
    Thakur VS; Deb G; Babcook MA; Gupta S
    AAPS J; 2014 Jan; 16(1):151-63. PubMed ID: 24307610
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epigenetic biomarkers for human cancer: the time is now.
    Mulero-Navarro S; Esteller M
    Crit Rev Oncol Hematol; 2008 Oct; 68(1):1-11. PubMed ID: 18430583
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNAs, diet, and cancer: new mechanistic insights on the epigenetic actions of phytochemicals.
    Parasramka MA; Ho E; Williams DE; Dashwood RH
    Mol Carcinog; 2012 Mar; 51(3):213-30. PubMed ID: 21739482
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epi-drugs to fight cancer: from chemistry to cancer treatment, the road ahead.
    Mai A; Altucci L
    Int J Biochem Cell Biol; 2009 Jan; 41(1):199-213. PubMed ID: 18790076
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic and epigenetic studies for determining molecular targets of natural product anticancer agents.
    Wang Y; Li Y; Liu X; Cho WC
    Curr Cancer Drug Targets; 2013 Jun; 13(5):506-18. PubMed ID: 23597195
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epigenetic alterations in cancer and personalized cancer treatment.
    Miozzo M; Vaira V; Sirchia SM
    Future Oncol; 2015; 11(2):333-48. PubMed ID: 25591842
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epigenetics/epigenomics of triterpenoids in cancer prevention and in health.
    Li S; Kuo HD; Yin R; Wu R; Liu X; Wang L; Hudlikar R; Peter RM; Kong AN
    Biochem Pharmacol; 2020 May; 175():113890. PubMed ID: 32119837
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Histone modification therapy of cancer.
    Biancotto C; Frigè G; Minucci S
    Adv Genet; 2010; 70():341-86. PubMed ID: 20920755
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A new paradigm in toxicology and teratology: altering gene activity in the absence of DNA sequence variation.
    Reamon-Buettner SM; Borlak J
    Reprod Toxicol; 2007 Jul; 24(1):20-30. PubMed ID: 17596910
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epigenetic alternations and cancer chemotherapy response.
    Lv JF; Hu L; Zhuo W; Zhang CM; Zhou HH; Fan L
    Cancer Chemother Pharmacol; 2016 Apr; 77(4):673-84. PubMed ID: 26707728
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epigenetic alterations as a universal feature of cancer hallmarks and a promising target for personalized treatments.
    Schnekenburger M; Florean C; Dicato M; Diederich M
    Curr Top Med Chem; 2016; 16(7):745-76. PubMed ID: 26303418
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epigenetic targeting in pancreatic cancer.
    van Kampen JG; Marijnissen-van Zanten MA; Simmer F; van der Graaf WT; Ligtenberg MJ; Nagtegaal ID
    Cancer Treat Rev; 2014 Jun; 40(5):656-64. PubMed ID: 24433955
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of curcumin as an epigenetic agent.
    Fu S; Kurzrock R
    Cancer; 2010 Oct; 116(20):4670-6. PubMed ID: 20597137
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plant-derived epigenetic modulators for cancer treatment and prevention.
    Schnekenburger M; Dicato M; Diederich M
    Biotechnol Adv; 2014 Nov; 32(6):1123-32. PubMed ID: 24699435
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epigenetics in prostate cancer: biologic and clinical relevance.
    Jerónimo C; Bastian PJ; Bjartell A; Carbone GM; Catto JW; Clark SJ; Henrique R; Nelson WG; Shariat SF
    Eur Urol; 2011 Oct; 60(4):753-66. PubMed ID: 21719191
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epigenetic therapy for solid tumors: from bench science to clinical trials.
    Juo YY; Gong XJ; Mishra A; Cui X; Baylin SB; Azad NS; Ahuja N
    Epigenomics; 2015; 7(2):215-35. PubMed ID: 25942532
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.